Cargando…
An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty
Autores principales: | Qi, Xingshun, Guo, Xiaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108399/ https://www.ncbi.nlm.nih.gov/pubmed/27904533 http://dx.doi.org/10.5114/aoms.2016.62921 |
Ejemplares similares
-
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease
por: Adhyaru, Kunal, et al.
Publicado: (2022) -
Portal Fibrotic Cord is Associated with Transjugular Intrahepatic Portosystemic Shunt Failure and Death in Cirrhotic Patients
por: Yang, Yunshu, et al.
Publicado: (2023) -
Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature
por: Qi, Xingshun, et al.
Publicado: (2011) -
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020) -
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
por: Tsuruya, Kota, et al.
Publicado: (2023)